脊柱关节炎疾病结局的个体与国家社会经济决定因素:多国横断面研究
基于COMOSPA多国横断面研究3370例SpA患者,分析个体和国家层面社会经济地位对疾病活动度(ASDAS)和功能(BASFI)的影响。低教育程度和女性患者ASDAS≥2.1的OR均为1.7,功能稍差;欠发达国家患者ASDAS更差但BASFI无显著差异;生物制剂使用未介导该关系。
要点
- 低教育程度和女性SpA患者疾病活动度更高(ASDAS≥2.1的OR均为1.7)。
- 欠发达国家SpA患者ASDAS更差,但BASFI无显著差异。
- 生物制剂使用未介导个体或国家社会经济地位与疾病活动度的关系。
核心结论
- SpA患者中存在个体和国家层面的健康不平等,女性和低教育程度者疾病活动度更差、功能稍差,欠发达国家患者疾病活动度更高但功能相似。
研究设计与样本
- COMOSPA多国横断面研究,纳入全球22个国家3370例SpA患者,采用多水平回归模型分析个体和国家层面社会经济因素对ASDAS和BASFI的影响。
主要发现
- 低教育程度患者ASDAS≥2.1的OR为1.7(95%CI 1.3-2.2),女性患者OR为1.7(95%CI 1.4-2.0),两者功能也稍差。
- 独立于个体社会经济地位和临床混杂因素,国家间存在较大差异,欠发达国家患者ASDAS更差,但BASFI模式不显著。
- 生物制剂使用未介导个体或国家层面社会经济地位与疾病活动度的关系。
临床怎么用
- 临床应关注女性和低教育程度SpA患者,其疾病活动度和功能可能更差。
- 来自欠发达国家的SpA患者疾病活动度可能更高,需加强疾病评估和管理。
局限性
- 横断面设计无法推断因果关系。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To explore the independent contribution of individual-level and country level socioeconomic status (SES) determinants to disease activity and physical function in patients with spondyloarthritis (SpA). METHODS: Data from the cross-sectional, multinational (n=22 countries worldwide) COMOSPA (COMOrbidities in SpA) study were used. Contribution of individual SES factors (gender, education) and country of residence to Ankylosing Spondylitis Disease Activity Score (ASDAS) and Bath Ankylosing Spondylitis Functional Index (BASFI) was explored in multilevel regression models, adjusting for clinical and demographic confounders. Next, the additional effects of national macroeconomic indicators (gross domestic product [GDP], Human Development Index, healthcare expenditure and Gini index) were explored. The mediating role of uptake of biologic disease-modifying antirheumatic drugs between education or GDP and ASDAS was explored by testing indirect effects. RESULTS: In total, 3370 patients with SpA were included: 65% were male, with a mean age of 43 (SD 14), ASDAS of 2.0 (SD 1.1) and BASFI score of 3.1 (SD 2.7). In adjusted models, patients with low education and female patients had an OR of 1.7 (95% CI 1.3 to 2.2) and an OR of 1.7 (95% CI 1.4 to 2.0), respectively, of having ASDAS ≥2.1. They also reported slightly worse function. Large country differences were observed independent of individual SES and clinical confounders. Patients from less SES developed countries have worse ASDAS, while patterns for BASFI were insignificant. Uptake of biologicals did not mediate the relationship between individual-level or country-level SES and disease activity. CONCLUSIONS: Individual-level and country-level health inequalities exist also among patients with SpA. Women and lower educated persons had worse disease activity and somewhat worse physical function. While patients in less socioeconomically developed countries had higher disease activity, they reported similar physical function.
引用
- Putrik P, Ramiro S, Moltó A, et al. Individual-level and country-level socioeconomic determinants of disease outcomes in SpA: multinational, cross-sectional study (ASAS-COMOSPA). Ann Rheum Dis. 2019. PMID: 30674477. doi:10.1136/annrheumdis-2018-214259
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。